Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for COMPASS Pathways plc (CMPS)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021
4 days ago | GlobeNewsWire
a week ago | InvestorPlace
a week ago | GlobeNewsWire
a week ago | GlobeNewsWire
3 weeks ago | GlobeNewsWire
3 weeks ago | The Motley Fool
a month ago | GlobeNewsWire
a month ago | GlobeNewsWire
a month ago | GlobeNewsWire
About:
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom.